Angeles Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Buy
2,757
+170
+7% +$20.9K 0.02% 334
2026
Q1
$305K Buy
2,587
+555
+27% +$77.5K 0.02% 317
2025
Q4
$333K Buy
2,032
+125
+7% +$19.6K 0.02% 277
2025
Q3
$255K Buy
1,907
+225
+13% +$27.3K 0.02% 286
2025
Q2
$209K Buy
+1,682
New +$214K 0.01% 323
2025
Q1
Sell
-1,526
Closed -$220K 382
2024
Q4
$220K Buy
+1,526
New +$219K 0.02% 275

Other funds holding RGEN

Angeles Wealth Management's RGEN Position: Q2 2026 in Review

Angeles Wealth Management increased its Repligen (RGEN) stake by 6.6% in Q2 2026, buying an estimated $20.9K and bringing the position to 2,757 shares worth $376K. The position accounts for 0.02% of the portfolio, ranked #334.

Angeles Wealth Management first reported a position in RGEN in Q4 2024 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Angeles Wealth Management held 2,757 shares of Repligen worth $376K as of Q2 2026.
  • Angeles Wealth Management bought 170 Repligen shares in Q2 2026, an estimated $20.9K.
  • Repligen made up 0.02% of Angeles Wealth Management's portfolio in Q2 2026, its #334 holding.
  • Angeles Wealth Management first reported a position in Repligen in Q4 2024 and has held it in 6 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.